12:00 AM
 | 
Jan 16, 2012
 |  BC Week In Review  |  Company News  |  Other News

Royal DSM ophthalmic, drug delivery news

DSM joined the PANOPTES consortium, which is working to develop novel peptide-based nanomaterials for drug delivery to the posterior eye segment. DSM will contribute its "proprietary knowledge" on the preparation of tailored amino acid-based...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >